Paclitaxel-Loaded Magnetic Nanoparticles Based on Biotinylated N-Palmitoyl Chitosan: Synthesis, Characterization and Preliminary In Vitro Studies.
Vlad Constantin UrsachiGianina DodiAlina Gabriela RusuCosmin Teodor MihaiLiliana VereștiucVera BalanPublished in: Molecules (Basel, Switzerland) (2021)
A considerable interest in cancer research is represented by the development of magnetic nanoparticles based on biofunctionalized polymers for controlled-release systems of hydrophobic chemotherapeutic drugs targeted only to the tumor sites, without affecting normal cells. The objective of the paper is to present the synthesis and in vitro evaluation of the nanocomposites that include a magnetic core able to direct the systems to the target, a polymeric surface shell that provides stabilization and multi-functionality, a chemotherapeutic agent, Paclitaxel (PTX), and a biotin tumor recognition layer. To our best knowledge, there are no studies concerning development of magnetic nanoparticles obtained by partial oxidation, based on biotinylated N-palmitoyl chitosan loaded with PTX. The structure, external morphology, size distribution, colloidal and magnetic properties analyses confirmed the formation of well-defined crystalline magnetite conjugates, with broad distribution, relatively high saturation magnetization and irregular shape. Even if the ability of the nanoparticles to release the drug in 72 h was demonstrated, further complex in vitro and in vivo studies will be performed in order to validate the magnetic nanoparticles as PTX delivery system.
Keyphrases
- magnetic nanoparticles
- drug delivery
- cancer therapy
- wound healing
- molecularly imprinted
- case control
- healthcare
- induced apoptosis
- cell cycle arrest
- emergency department
- drug induced
- reduced graphene oxide
- ionic liquid
- hydrogen peroxide
- young adults
- squamous cell carcinoma
- gold nanoparticles
- mass spectrometry
- squamous cell
- adverse drug
- cell proliferation
- aqueous solution